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Methods: Retrospective analysis of the recruitment, baseline characteristics and outcomes during minimum
12-month exposure to all four seasons in 1598 disease-management trial patients hospitalised with chronic
heart disease. Seasonality was prospectively defined as ≥4 hospitalisations (all-cause) AND N45% of related
bed-days occurring in any one season during median 988 (IQR 653, 1394) days follow-up.
Results: Patients (39% female) were aged 70 ± 12 years and had a combination of coronary artery disease (58%),
heart failure (54%), atrial fibrillation (50%) and multimorbidity. Overall, 29.9% of patients displayed a pattern of
seasonality. Independent correlates of seasonality were female gender (adjusted OR 1.27, 95% CI 1.01–1.61; p =
0.042), mild cognitive impairment (adjusted OR 1.51, 95% CI 1.16–1.97; p = 0.002), greater multimorbidity (OR
1.20, 95% CI 1.15–1.26 per Charlson Comorbidity Index Score; p b 0.001), higher systolic (OR 1.01, 95%CI 1.00–
1.01 per 1 mmHg; p= 0.002) and lower diastolic (OR 0.99, 95% CI 0.98–1.00 per 1 mmHg; p= 0.002) blood pres-
sure. These patientsweremore than two-foldmore likely to die (adjustedHR2.16, 95% CI 1.60–2.90; pb 0.001)with
the highest and lowest number of deaths occurring during spring (31.7%) and summer (19.9%), respectively.
Conclusions: Despite high quality care and regardless of their diagnosis, we identified a significant proportion of
“seasonal frequent flyers” with concurrent poor survival in this real-world cohort of patients with chronic heart
disease.





Coronary artery disease1. Introduction
Despite gains in reducing prematuremortality, the burden of cardio-
vascular disease (CVD) remains substantial; by 2035 it is estimated that
N130 million adults (45.1%) in the United States will have developed
CVD at an annual cost of ~$US750 billion in health care expenditureonary artery disease; CVD,
n-Geiger Climate Classification
liability and freedom from bias
pe Town 8001, South Africa.[1]. Much of this burden is due to a combination of coronary artery
disease (CAD), atrial fibrillation (AF), and heart failure (HF) requiring
long-termmanagement in the community and episodic hospital admis-
sions during periods of clinical instability [2] [3]. An important but often
overlooked contributor to the growing burden of CVD worldwide is the
phenomenon of “seasonality” characterised by annual peaks and
troughs in cardiovascular event rates coinciding with seasonal changes
in climatic conditions and acuteweather events [4–7]. Typically, season-
ality results in a 10–20% variation in hospitalisation (both de novo and
recurrent) andmortality rates throughout the year; the annual problem
of “hospital bed-block” and “ambulance ramping” during the winter
months, as well as random spikes in mortality during extreme heat-
waves or cold-snaps, being the most recognisable manifestation of this
127J. Loader et al. / International Journal of Cardiology 279 (2019) 126–132phenomenon [6]. However, there has been relatively little focus on this
phenomenon from a clinical perspective [6].
2. Study aims & hypothesis
We hypothesise that a natural starting point of any investigation of
seasonality from a cardiovascular perspective is predominantly older
patients with chronic forms of heart disease and multimorbidity. [6]
This is for two principal reasons – 1) it is within this growing patient
population that rates of recurrent hospitalisation and potentially
preventable mortality are highest, with a significant component of
recurrent “frequent flyers” to hospital the main focus of hospital avoid-
ance programs; AND 2) if, as we've hypothesised [6], that seasonality is
largely driven by a complex interaction between physiology, clinical
profile, environment and behaviours, it is within this patient population
that we are most likely to identify such an interaction.
Our specific aim, therefore, was to retrospectively examine the prev-
alence and characteristics of seasonality in a large, real-world cohort of
patients hospitalised with a combination of CAD, HF and/or AF
followed-up for at least 12 months. Apart from ensuring all patients
were exposed to all four seasons during follow-up, this cohort had
been subject to comprehensive profiling to facilitate identification of
potential bio-behavioural correlates of any observed seasonality.
Moreover, in selecting patients subject to high-levels of care, we had
the opportunity to determine if seasonality explains, at least partially,
why some patients appear to be “resistant” to otherwise provenmodels
of care designed to reduce morbidity and mortality [8–10].
3. Methods
Consistent with a previous report examining composite health outcomes across three
diseasemanagement trials [11], we conducted a retrospective analysis of the timing of re-
cruitment, baseline characteristics and health outcomes of patients admitted to hospital
with chronic heart disease (n = 2026) who participated in one of four disease manage-
ment trials. Details of the design of each pragmatic disease management trial (all four
trials conformed to the ethical guidelines of the 1975 Declaration of Helsinki and were
prospectively registered via www.anzctr.org.au), rationale and individual trial outcomes
reported according to CONSORT guidelines for pragmatic trials of health service
interventions [12,13], have been published previously [14–17].
3.1. Study cohort
This composite study cohort comprises patients enrolled in a series of disease man-
agement trials undertaken by our group with the following key features: 1) chronic
heart disease (most presented with acute coronary syndrome/CAD), but not HF (n =
624), enrolled in the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF)
Study [14]; 2) chronic AF, but not HF (n = 335), enrolled in the Standard versus Atrial
Fibrillation spEcific managemenT StrategY (SAFETY) Trial [15]; and 3) chronic HF with
multimorbidity enrolled in the Which Heart failure Intervention is most Cost-effective &
consumer friendly in reducing heart failure Hospital care (WHICH?) Trial (n = 280)
[16]; and 4) the subsequentWhich Heart failure Intervention is most Cost-effective in re-
ducing Hospital stay (WHICH? II) Trial (n = 787) [17].
3.2. Study eligibility
All 2026 patients who underwent standardized profiling (during their index admis-
sion) and study follow-up (post-randomization) as part of these trials were eligible for in-
clusion. However, in order to identify and characterize underlying seasonality both at the
point of study recruitment and during study follow-up, we applied two key inclusion
criteria: 1) recruited during a full 12-month calendar (January to December) period for
that study and 2) subject to a minimum 12 months follow-up and, subsequent, exposure
to all four seasons/climatic conditions. Overall, 1598 patients (from NIL-CHF (n = 503
31.5%), SAFETY (n = 281, 17.6%), WHICH? I (n = 211, 13.2%) and WHICH? II (n = 603,
37.7%) trial cohorts fulfilled these criteria.
3.3. Study sites
With the exception of the single-centre NIL-CHF Study, study patients were recruited
from tertiary hospitals across Australia subject to varying climates and acuteweather con-
ditions, but with four distinct seasons that appear critical to provoking seasonality [6]. On
this basis, patients lived inMelbourne, Victoria (main Köppen-Geiger Climate Classification –
Marine West Coast Climate), Adelaide, South Australia (Mediterranean Climate), Canberra,
Australian Capital Territory (Marine West Coast Climate), Sydney, New South Wales
(Humid Subtropical) and Brisbane, Queensland (Humid Subtropical) [18].3.4. Baseline profile
Equivalent and highly stringent methods for comprehensive profiling of patients dur-
ing their index (qualifying) admission were applied to each study cohort (see Table 1).
This included socio-demographic status, past medical history, clinical profile, in-hospital
management and post-discharge care. The primary diagnosis of all patients was deter-
mined by the treating cardiologist confirmed with documented cardiac structure and
function evaluated by echocardiography (all cases) and other cardiac investigations (in-
cluding coronary angiography), where appropriate.3.5. Seasonality
Firstly, we examined potential differences in the absolute number and characteristics
of trial patients according to the season in which they were recruited. This comprised the
summer (December to February), autumn (March to May), winter (June to August) and
spring (September to November) periods of 2008–2017. With minimal loss to follow-up,
all subsequent readmissions and deaths were documented via individually linked, electronic
records during a median of 988 (IQR 653, 1394) days follow-up.
There are currently no published or agreed clinical definitions of seasonality. To iden-
tify patterns of seasonality using a set of conservative parameters, therefore,we firstly cat-
egorized all events (readmission or death) during a minimum 12-month follow-up post-
index hospitalisation according to the season in which it occurred. In order to minimise
the possibility of random clustering of events in one particular season, we then applied a
prospectively formulated/high-threshold definition to observed patterns of
hospitalisation and bed-stay: 1)minimumof four hospitalisations for any reason including
their index admission; AND 2) N45% of related bed-days occurring in one season during
median 988 (IQR 653, 1394) days follow-up.3.6. Statistical analyses
No formal analysis of study power was conducted. However, we hypothesised that
N10% (N150 patients) would exhibit seasonality. Profiling and outcome data from the
four studies were pooled and analyzed using SPSS v24.0. Discrete variables are summa-
rized by frequencies and percentages; and continuous variables by standard measures of
central tendency and dispersion using means (standard deviation [SD]) and medians
(interquartile range [IQR])where appropriate. Between group comparisonswere assessed
using the one-way analysis of variance (ANOVA), the Mann Whitney U test, the Kruskal-
Wallis test and the Chi-squared test (with calculation of odds ratios [OR] and 95%
confidence intervals [CIs]), where appropriate. Survival data were used to generate
Kaplan-Meier survival curves and group comparisons made with the log-rank test. A
Cox Proportional Hazards Model using comprehensive baseline profiling data was con-
structed to identify the independent correlates of all-cause mortality using a backwards,
step-wise approach (the assumption of proportional hazards being confirmed).4. Results
4.1. Baseline characteristics
The baseline characteristics of the cohort according to the season in
which their index admission occurred are summarized in Table 1. Over-
all, 118 more patients were identified and recruited in autumn/winter
than spring/summer: a marked summer trough (equivalent to 60
fewer patients when assuming an even rate of recruitment over the
four seasons) in recruitment being evident. A number of potentially im-
portant differences (from a socio-economic, behavioural and clinical
perspective) were evident. For example, compared to those recruited
in the heat of summer, those recruited in the colder/wetter winter sea-
son were less educated (24% versus 16%), had higher risk alcohol use
(16% versus 12%), a higher frequency of total cholesterol levels
≥4.0 mmol/L (50% versus 47%), higher systolic BP (135 [24] versus 132
[24] mmHg) and heart rate (86 [27] versus 84 [26] beats/min), less
type 2 diabetes (33% versus 37%), more HF (57% versus 52%) and were
more likely to be specifically admitted with a primary diagnosis of
heart disease (77% versus 72%); p b 0.05 for all comparisons.4.2. Health outcomes during long-term follow-up
During a total of 4558 patient-years follow-up, 1158 patients
(72.5%) accumulated 5825 readmissions and 35,292 bed-days. Beyond
minimum 12-month follow-up, 186 patients (11.6%) died.
Table 1












Female 624 (39%) 122 (36%) 164 (38%) 166 (39%) 172 (43%)
Age (years) 70 (12) 70 (12) 70 (12) 71 (12) 71 (12)
Living alone 686 (43%) 145 (43%) 186 (43%) 179 (42%) 176 (44%)
b12 years educationa 350/1581 (22%) 55/335 (16%) 97/426 (23%) 101/426 (24%) 97/394 (25%)
Low income statusa 99/1595 (6%) 20/338 (6%) 21/427 (5%) 29/429 (7%) 29/401 (7%)
Behavioural profile
Abdominal obesitya 610/1503 (41%) 123/310 (40%) 147/402 (37%) 172/406 (42%) 168/385 (44%)
Meeting exercise guidelinesa 604/1589 (38%) 127/335 (38%) 174/425 (41%) 158/428 (37%) 145/401 (36%)
Current smoker 274 (17%) 63 (19%) 73 (17%) 71 (17%) 67 (17%)
High-risk alcohol use 238 (15%) 41 (12%) 70 (16%) 68 (16%) 59 (15%)
Total cholesterol ≥4.0 mmol/La 384/793 (48%) 82/175 (47%) 115/230 (50%) 101/203 (50%) 86/185 (46%)
Clinical presentation
Systolic blood pressure (mmHg)a 134 (24) 132 (24) 135 (23) 135 (24) 132 (23)
Diastolic blood pressure (mmHg)a 75 (15) 75 (15) 77 (15) 76 (15) 73 (14)
Heart rate (beats/min)a 85 (27) 84 (26) 83 (26) 86 (27) 86 (27)
Left ventricular ejection fractiona 47 (17) 46 (16) 48 (17) 48 (17) 47 (17)
Grip strength (kg)a 20 (10) 21 (11) 22 (10) 20 (11) 21 (11)
Hba1c (%)a 6.6 (1.5) 6.7 (1.7) 6.5 (1.4) 6.7 (1.4) 6.7 (1.4)
Renal failure (eGFR b 60 ml s/min/1.73 m2)a 622/1553 (40%) 130/327 (40%) 137/411 (33%) 176/419 (42%) 179/396 (45%)
Anaemia (sex-specific)a 617/1551 (40%) 124/326 (38%) 153/414 (37%) 170/415 (41%) 170/396 (43%)
Mild cognitive impairmenta 676/1258 (54%) 157/279 (56%) 159/328 (48%) 180/320 (56%) 180/331 (54%)
Depressive symptomsa 271/995 (27%) 61/227 (27%) 81/286 (28%) 68/258 (26%) 61/224 (27%)
Clinical profile
Type 2 diabetes 557 (35%) 124 (37%) 139 (32%) 143 (33%) 151 (38%)
Charlson comorbidity score 5.7 (2.7) 5.7 (2.6) 5.4 (2.7) 5.8 (2.9) 5.9 (2.5)
Coronary artery disease 931 (58%) 196 (58%) 252 (59%) 244 (57%) 239 (59%)
Heart failure 861 (54%) 176 (52%) 197 (46%) 243 (57%) 245 (61%)
Atrial fibrillation 803 (50%) 169 (50%) 179 (42%) 225 (52%) 230 (57%)
Respiratory disease 287 (18%) 64 (19%) 72 (17%) 80 (19%) 71 (18%)
In-hospital management at index admission
Median length of stay 5 (3–9) 5 (3–9) 5.0 (3.0–10.0) 5 (3–9) 5 (3–8)
Coronary revascularisation 442 (28%) 101 (30%) 123 (29%) 118 (28%) 100 (25%)
Primary discharge diagnosisa
Acute coronary syndrome 22/989 (2%) 6/225 (4%) 4/286 (1%) 6/258 (2%) 6/220 (3%)
Acute heart failure 150/989 (15%) 33/225 (15%) 37/286 (13%) 42/258 (16%) 38/220 (17%)
Stable coronary artery disease 296/989 (30%) 66/225 (29%) 94/286 (33%) 78/258 (30%) 58/220 (26%)
Atrial fibrillation 186/989 (19%) 42/225 (19%) 38/286 (13%) 58/258 (22%) 48/220 (22%)
Cerebrovascular disease 18/989 (2%) 6/225 (3%) 4/286 (1%) 3/258 (1%) 5/220 (2%)
Other cardiovascular 31/989 (3%) 8/225 (4%) 8/286 (3%) 10/258 (4%) 5/220 (2%)
Non-cardiovascular 286/989 (29%) 64/225 (28%) 101/286 (35%) 60/258 (23%) 61/220 (28%)
Discharge pharmacotherapy
ACEi 786 (49%) 175 (52%) 196 (46%) 214 (50%) 201 (50%)
ARBs 376 (24%) 78 (23%) 111 (26%) 102 (24%) 85 (21%)
β-blocker 1015 (64%) 216 (64%) 260 (61%) 280 (65%) 259 (64%)
Diuretic 907 (57%) 184 (54%) 207 (48%) 255 (59%) 261 (65%)
Nitrate therapy 529 (33%) 108 (32%) 128 (30%) 146 (34%) 147 (37%)
Anti-arrhythmic agent 251 (16%) 56 (17%) 75 (17%) 57 (13%) 63 (16%)
Anti-platelet/anti-coagulant 1218 (76%) 245 (72%) 337 (79%) 335 (78%) 301 (75%)
Data are presented asmean (SD),median (IQR), or number of patients (%). Depressive symptomsdetermined bypositive response to two-itemArroll tool [27] andmild cognitive impairment
score ≤ 26 on the Montreal Cognitive Assessment (MoCA) tool [28]. ACEi, angiotensin converting enzyme inhibitors; ARBs, angiotensin II receptor blockers; BP, blood pressure; eGFR,
estimated glomerular filtration rate.
a Data not available for all patients.
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Fig. 1 shows the pattern of index and recurrent hospitalisation (6265
admissions and 38,499 bed-days combined) and all-cause mortality ac-
cording to the month (and season) in which it occurred; both overall
and according to the 3 main forms of heart disease diagnosed during
the index admission (HF, AF, CAD). Overall, hospital activity levels (in
terms of bed-days) reached peak levels in the winter months (a differ-
ential of 2029 days equivalent to 19% more bed-days) versus trough
levels in the summer months. Alternatively, peak mortality (22 more
deaths equivalent to a 37%difference) occurred during spring compared
to an equivalent trough in summer.4.4. Seasonal patterns
Overall, 478/1598 patients (29.9%, 95% CI 27.7% to 32.2%) demon-
strated seasonality during study follow-up. This phenomenon was
evident in all four seasons, with 107 (6.7% of total cohort), 110 (6.9%),
128 (8.0%) and 117 (7.3%) of these 478 patients displaying a predomi-
nant pattern of recurrent hospital stay in summer (0.64 ± 0.14 of all
bed-days occurred in that season), autumn (0.63 ± 0.14), winter
(0.62 ± 0.16) and spring (0.65 ± 0.16), respectively. A further 16 pa-
tients demonstrated dual seasonality (N45% bed-stay in two different
seasons) with most (12/16 patients) admitted across the winter/spring
months.
Fig. 1. Pattern of hospital stay and all-cause mortality according to month and season. Legend: Rates of hospital stay (bed-days per day of the month) are adjusted for the number of days
per month and individual contributions to all-cause admissions (BLACK BARS) activity levels are counted once (n= 1598). Figures for HF (PURPLE BARS), AF (RED BARS) and CAD (BLUE
BARS) are based on diagnosis at index discharge (patients with multiple diagnoses can contribute to two or three categories).
129J. Loader et al. / International Journal of Cardiology 279 (2019) 126–132On an adjusted basis, those displaying seasonality were more likely
to be female (33.8% versus 27.4% of males - OR 1.27, 95% CI 1.01, 1.61;
p = 0.042), with mild cognitive impairment (32.8% versus 22.3% intact
cognition among 918 patients – OR 1.51, 95% 1.16, 1.97; p = 0.002),
greater multimorbidity (mean Charlson Index of Comorbidity Score
6.7 ± 2.6 versus 5.2 ± 2.6 – OR 1.203, 95% CI 1.15, 1.26 per unit score
increase; p b 0.001) and higher systolic BP (137 ± 24 versus 133 ±
23 mmHg – OR 1.01, 95% CI 1.10, 1.01 per unit score increase; p =
0.002) and lower diastolic BP (74 ± 14 versus 76 ± 15 mmHg – ORTable 2






































































(10.99, 95% CI 0.98, 1.00 per unit score increase; p = 0.002). Importantly,
neither the specific cardiac diagnosis(es) nor the type of post-discharge
management modulated observed seasonality.
Table 2 summarises the pattern of seasonality evidence in the 1158
patients (72.5%) who experienced at least one hospital readmission.
Those who didn't demonstrate seasonality (59% of this sub-group) con-
tributed to a steady baseline of 42%–46% of hospital activity each season.
By contrast, those demonstrating seasonality in the summer (9.2% of








































































130 J. Loader et al. / International Journal of Cardiology 279 (2019) 126–132spring (10.1%) contributed disproportionately to 22%–26% of admis-
sions and 31%–37% of bed-stay in their equivalent peak seasons.
Fig. 2 demonstrates that, on an adjusted basis, seasonality (along
with advancing age, longer stay at index admission, a diagnosis of HF
and greater comorbidity) was independently associated with a 2.2-
fold increased risk of all-cause mortality; overall 103/478 (21.6%)
patients displaying seasonality versus 68/680 (10.0%) of the rest died
during follow-up. Moreover, the pattern of mortality according to sea-
son, was markedly different (p b 0.001) with 13 (12.6%), 24 (23.3%),
31 (30.1%) and 35 (34.0%) of deaths among those displaying seasonality
occurring in the summer, autumn, winter and spring, respectively
(p b 0.001). The equivalent distribution of deaths in the remaining
cohort was more even, but also with some seasonal variations:
15 (22.0%) in autumn, 22 in spring (32.4%), 19 (27.9%) in summer and
12 (17.6%) in winter.
5. Discussion
The primary aim of this unique study of seasonality from a clinical
perspective, was to identify and characterize seasonality within a real-
world cohort of patients admitted to hospital with chronic heart disease
andmultimorbidity. Overall, despite intensive intervention tominimize
recurrent hospitalisation and premature mortality [11,15,16,19], 29.9%
of patients displayed a distinctive pattern of seasonality. Moreover, sea-
sonality was not confined to winter. As previously postulated, a combi-
nation of socio-economic, behavioural, environmental and clinical/
biological factors, some of which might be amenable to modification,
appear to contribute to this phenomenon [6]. Critically, although it is
true our definition of seasonality mandated that individuals be
“frequent flyers” in terms of recurrent hospitalisation, it is important to
note that “seasonal frequent flyers” make-up the majority of this high-
risk/high-cost group. On this basis, we have yet to identify how to define
seasonality at the individual level. However, the conservative definition
we applied in this study represent a good starting point. Beyond
explaining high-levels of recurrent hospitalisation despite the applica-
tion of high-quality care, on an adjusted basis, those displaying seasonal-
ity had a more than two-fold risk of dying (predominantly in spring).
Despite the retrospective nature of our analyses and notwithstanding
many epidemiological reports [20–23], to our knowledge, this study rep-
resents one of the few studies to address this phenomenon from aFig. 2. Long-term survival profile (Kaplan-Meier Curves) according to presence versus
absence of seasonality. Legend: Box insert shows the results of a Cox-Proportional
Hazards Model.clinical perspective. Given a lack of evidence, current clinical guidelines
focussing on chronic heart disease rarely address this phenomenon
[24]. While reinforcing that this phenomenon is typically characterized
by winter peaks and summer troughs in morbid and fatal events, we
found evidence of seasonal vulnerability across all four seasons. For ex-
ample, peak mortality occurred in Spring. While this may highlight the
arbitrary definition of each season (many deaths occurred in early
spring), it highly possible that the provocation of clinical instability dur-
ing winter resulted in many individuals becoming fatally vulnerable to
any further provocations of cold/climatic instability in typically variable
Spring conditions. This may also reflect the unique Australian events
(e.g. the deadly asthma thunderstorm in the spring of 2016 [25]).
With a predominantly warmer/milder climate, Australia potentially
represents an ideal “laboratory” to study seasonality/winter peaks inde-
pendent of extremely cold temperatures. [21] Accordingly, mechanisms
underlying seasonal patterns of morbidity and mortality are complex
and go beyond a simple, linear relationship between ambient tempera-
ture and risk of a cardiovascular event. Indeed, counterintuitively, the
magnitude of seasonality at the population level appears to be greater
in those populations living in milder climates [4,26]; suggesting that
this phenomenon is driven by an interaction between numerous envi-
ronmental, physiological and behavioural factors at the individual
level. On this basis, an individual's vulnerability to seasonality may be
dependent on their ability to adapt bio-behaviourally (i.e. their
resilience) to provocative variations in climatic/environmental condi-
tions. Behavioural seasonality has been demonstrated in several studies
[27,28],where peaks in alcohol consumption and energy intake (includ-
ing increases in fat-intake) and troughs in physical activity levels, occur
in the cooler months; coinciding with winter peaks in cardiovascular
events [20,29,30]. While excessive alcohol consumption has been di-
rectly linked to the onset of AF [31], poorer lipid profiles and increased
oxidative stress, in conjunction with other “protective” mechanisms
(i.e. shivering) in response to exposure to the cold, impair vascular reac-
tivity and provoke hypertension and tachycardia with deleterious car-
diac consequences [32]. These (mal)adaptations to behaviour and
environment, combined with reductions in plasma volume and in-
creases in blood viscosity [33,34], intensify blood shear stress triggering
platelet activation and inflammation [35,36].
Alternatively, provocation of cardiovascular events by warmer
weather/acute heat-waves may be more acute. For example, heat stress
may rapidly provoke cardiac arrhythmias and cardiac arrest due the cas-
cade effect of excessive sweating leading to a combination of hypoten-
sion and electrolyte imbalance [37].
Traditionally, seasonal vulnerability has not been identified as an im-
portant therapeutic target. Subsequently, there has been little effort
from a clinical management perspective to attenuate its deleterious ef-
fects. However, considering that it is likely underpinned, at least in part,
by adverse interactions between environmental and, bio-behavioural
factors in vulnerable patients, it is highly plausible that this phenome-
non can be addressed at the individual level. Critically, as reflected by
our findings, this phenomenon persists among those exposed to
evidence-based management specifically designed (and proven) to
minimize recurrent hospitalisation and premature mortality [11]. This
is most probably due to a combination of three interrelated factors –
1) these programmes are facing an increasing proportion of patients
with vulnerability to seasonality (multimorbidity being a critical factor
in this regard); 2) they are not specifically geared to recognize and re-
spond to individual seasonal vulnerability from a clinical perspective;
and 3) an increasing frequence in extreme climatic events [38]. It is on
this basis that we have previously identified the need to develop
multi-faceted interventions specifically designed to identify high-risk/
vulnerable patients and promote their resilience to seasonal change/
acute weather events. [6] Avoiding high exertion activities such as
shovelling snow in the more extreme climates [39], applying greater
protection from the cold via housing design and clothing [40],maintain-
ing appropriate physical activity levels during winter, or avoiding
131J. Loader et al. / International Journal of Cardiology 279 (2019) 126–132exposure to high levels of air pollutants or smoke haze [41,42], are all
examples of measures that may increase the resilience to, or reduce
the influence of, environmental provocations in high-risk populations.
Individual behaviour, however, is not simply a function of intention
and awareness of the likely consequences of action/inaction, but the ca-
pacity to implement change through financial means/resources [43,44].
Therefore, future research should develop and test a globally applicable
health care program that aims to provide the necessary resources to an
at-risk individual, which may improve their seasonal resilience.
A number of limitations must be considered when interpreting the
findings of this study. Firstly, it was undertaken on a retrospective
basis and provides important, but not definitive insights into this
phenomenon. For example, it might be argued that the phenomenon
we observed reflects a secondary cluster of readmissions typically oc-
curring within 30–90 days among the sickest of patients. However,
this does not explain why seasonality occurs on a de novo as well as
recurrent basis, and study follow-up captured repeated exposure to sea-
sons. We plan to address the potentially complex issue of prospectively
identifying seasonally vulnerable individuals in future studies.
These will specifically focus on the bio-behavioural and environmental
factors (from the individual to the broader climatic conditions) that
drive vulnerability and, conversely, resilience to clinical instability on
a seasonal basis. The subsequent development of valid and reliable
seasonal risk score is entirely feasible on this basis [6]. Consistent with
past studies identifying the role ofmeteorologic conditions in provoking
cardiovascular events [6], comprehensive studies of seasonality from a
clinical perspective need to capture such data. By necessity, we
required patients to be exposed to all four seasons to reveal a
pattern of seasonality and examined outcomes on a rudimentary
monthly/seasonal basis rather than a continuous/actual climatic
conditions basis.
In conclusion, this study found clear evidence of seasonality in a real-
world cohort of older patients initially admitted to hospitalwith chronic
heart disease. Overall, we found that more than one in four patients had
multiple readmissions associated with a prolonged hospital stay in one
particular season. Distinctive patterns in respect to the demographic,
clinical and bio-behavioural profile of such “seasonal frequent flyers”
suggest that vulnerability to seasonality should be recognized as a clin-
ical phenomenon that can be both identified and then optimally man-
aged to prevent recurrent hospitalisation and premature mortality.
Pending further research to definitively phenotype seasonality (thereby
resulting in an agreed definition), these data should strongly encourage
clinicians to carefully consider their patient's vulnerability during char-
acteristically cold or warmer parts of the year and/or the random occur-
rence of extreme climatic conditions; the importance of air quality and
background levels of viral infections being important considerations in
this regard. Likewise, they should consider practical advice (e.g.
avoiding physical exertion during cold-snaps and/or prioritizing house-
hold heating) and interventions (e.g. influenza vaccination and/ormod-
ifying diuretic therapy during heatwaves) to promote seasonal
resilience in otherwise vulnerable individuals.
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